A new study describes a biomarker profile based on cerebrospinal fluid (CSF) tau and amyloid-β1–42 in a uniquely large population with a variety of dementia diagnoses. This study confirms the differential diagnostic value of CSF biomarkers and further highlights the important neuropathological overlap between dementia aetiologies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Skillbäck, T. et al. Cerebrospinal fluid tau and amyloid-β1–42 in patients with dementia. Brain http://dx.doi.org/10.1093/brain/awv181.
Blennow, K. et al. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimers Dement. 11, 58–69 (2015).
[No authors listed] Consensus report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer's Disease”. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiol. Aging 19, 109–116 (1998).
Jack, C. R. Jr et al. Introduction to the recommendations from the National Institute on Aging–-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 257–262 (2011).
De Meyer, G. et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch. Neurol. 67, 949–956 (2010).
Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367, 795–804 (2012).
Dubois, B. et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 9, 1118–1127 (2010).
Barker, W. W. et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis. Assoc. Disord. 16, 203–212 (2002).
Niemantsverdriet, E. et al. Overdiagnosing vascular dementia using structural brain imaging for dementia work-up. J. Alzheimers Dis. 45, 1039–1043 (2015).
Sieben, A. et al. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol. 124, 353–372 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
De Deyn, P. Cerebrospinal fluid biomarkers in dementias. Nat Rev Neurol 11, 549–550 (2015). https://doi.org/10.1038/nrneurol.2015.175
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2015.175
